DNA

#3010
Ginkgo Bioworks Holdings, Inc.
7.7250 USD
+16.34%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
7.5600
7.7400
年范围
5.3700
9.7200
日变化
+16.34%
每月变动
+10.36%
6个月变化
-13.01%
年变化
-13.01%
前一天收盘价
6.6400
开盘价
7.5600
买价
卖价
最低价
7.5600
High
7.7400
交易量
495
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 455.1906 M
  • Employee 485
  • Founded 2008
  • CEO Jason Kelly
  • Website www.ginkgobioworks.com
  • Headquarter Delaware, United States
  • FIGI BBG00YPS1KY3
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.47
市销率
2.71

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

新闻